Trial: 202111198

Phase II Study of The Combination of Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)

Phase

II

Principal Investigator

Ma, Cynthia

Disease Site

Breast

Learn more about this study at: clinicaltrials.gov